SGLT2 inhibitors in lupus nephropathy, a new therapeutic strategy for nephroprotection | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Letter

SGLT2 inhibitors in lupus nephropathy, a new therapeutic strategy for nephroprotection

Online download statistics by month:

Online download statistics by month: May 2022 to March 2024

	Abstract	Full	Pdf
May 2022	4302	218	193
Jun 2022	1917	138	98
Jul 2022	750	50	36
Aug 2022	1260	153	79
Sep 2022	1029	84	63
Oct 2022	806	58	49
Nov 2022	825	51	53
Dec 2022	547	31	31
Jan 2023	709	32	22
Feb 2023	533	43	29
Mar 2023	952	55	36
Apr 2023	683	36	15
May 2023	707	58	28
Jun 2023	617	41	29
Jul 2023	578	32	23
Aug 2023	602	64	37
Sep 2023	795	62	36
Oct 2023	1047	74	63
Nov 2023	818	46	36
Dec 2023	515	50	44
Jan 2024	815	32	61
Feb 2024	390	37	41
Mar 2024	874	65	48
Total	22071	1510	1150